LinusBio

LinusBio is a patient-centered, groundbreaking scientific precision exposure medicine company. The company's pipeline includes precise exposure drug biomarkers and target discovery across disease areas. Linus Biotechnology has developed a technology platform based on the breakthrough of exposome sequencing. Our platform includes proprietary laser and robotic hardware, data science, and a unique global dataset linking human exposure to clinical outcomes.